跳至主要内容
临床试验/NCT05351866
NCT05351866终止不适用

Feasibility and Acceptability of a Digital Therapeutic for Adolescent Depressive Symptoms in Hematology/Oncology and Weight Management

Limbix Health, Inc.2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2023年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
7
试验地点
2
主要终点
Feasibility of intervention: Module adherence

研究概览

简要总结

The primary aims of the proposed research are to assess the feasibility, acceptability, and preliminary evidence of efficacy of a self-guided, cognitive behavioral therapy (CBT)-based mobile app intervention (SparkRx) for the treatment of adolescents presenting with symptoms of depression in specialty medical care settings (e.g.Hematology/Oncology, Weight Management, etc.) at Children's Health System of Texas (CHST).

详细描述

The primary aims of the proposed research are to assess the feasibility, acceptability, and preliminary evidence of efficacy of a self-guided, cognitive behavioral therapy (CBT)-based mobile app intervention (SparkRx) for the treatment of adolescents presenting with symptoms of depression in specialty medical care settings (e.g.Hematology/Oncology, Weight Management, etc.) at Children's Health System of Texas (CHST).

These aims will be accomplished by evaluating:

  • Feasibility of recruiting and enrolling adolescents with mild to severe symptoms of depression from specialty care medical programs at CHST.
  • Retention, program adherence, completion, and withdrawal rates.
  • Perceived utility, usability, and enjoyment of the program by adolescents
  • Clinically significant changes between pre- to -post treatment and persistence of such gains at 1 month follow up.
  • Preliminary evidence of efficacy defined as a statistically significant difference in the eight-item Patient Health Questionnaire (PHQ-8) scores (p < 0.05) between Spark and an educational control at post-treatment.
  • Safety of the intervention, including rates of reported adverse events and adverse device effects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
13 Years 至 22 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 13 and 22
  • Moderate- severe self-reported symptoms of depression at baseline (PHQ-8 >= 5)
  • Have a comorbid medical condition and under the care of a healthcare provider at CHST
  • English fluency and literacy of adolescent; English or Spanish fluency and literacy of consenting legal guardian if under 18
  • Access to a compatible smartphone (or other device) and operating system (i.e., capable of installing the app from the Google Play or Apple App Store; list will be provided to participants) and regular internet access
  • Willing to provide informed consent/assent and have legal guardian willing to provide informed consent (if required)

排除标准

  • Concurrent psychotherapy: Have met with a psychologist for intervention (not assessment) for 30 minutes or more, more than once in the 3 weeks prior to enrollment as determined by the study team
  • Change in psychotropic medication (initiation or change in dose) within the past 30 days prior to enrollment
  • Suicide attempt within the past year as determined at eligibility screening
  • Active suicidal ideation with intent as determined at eligibility screening
  • Previously participated in user testing or clinical testing of the Spark app
  • Participating in any other psychiatric or psychological treatment based clinical research at the time of enrollment and up to two months prior to enrollment or planning to participate in any other psychiatric or psychological treatment based clinical research during the study intervention period (5 weeks)
  • Any condition, comorbidity, or event that, in the opinion of the investigator, will prevent the participant from adhering to the protocol or benefiting from the treatment (e.g., unable to provide informed assent or consent) or will prevent investigators from being able to ensure safety (e.g., will be leaving the country during study time period)

结局指标

主要结局

Feasibility of intervention: Module adherence

时间窗: 5 weeks

Adherence to program determined by average number of modules completed

Feasibility of intervention: Participant willingness

时间窗: Screening

Percent of eligible participants willing to participate

Feasibility of intervention: Eligibility

时间窗: Screening

Percent of potential participants eligible to participate

Feasibility of intervention: Completion adherence

时间窗: 5 weeks

Adherence to program determined by percent of enrolled participants completing all modules within 5 weeks and by post-treatment

Feasibility of intervention: Time adherence

时间窗: 5 weeks

Adherence to program determined by engagement with program (time spent in app)

次要结局

  • Adverse events(11 weeks)
  • Engagement(5 weeks)
  • Usability(5 weeks)
  • Change in depressive symptoms(5 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Digital Therapeutic for Adolescent Depressive... | 临床试验